Session: Commercialization of Biologics: Characterization and Improvement of Platforms to Aid Commercialization of Biologics


BIOT		Wednesday, August 22, 2007

3:00 PM-5:20 PM BCEC -- 107C, Oral
Commercialization of Biologics: Characterization and Improvement of Platforms to Aid Commercialization of Biologics

Organizers:	Shishir Gadam Frank Olsen
3:00 PM	220	Development and implementation of a robust chemically-defined and high-yielding GS-CHO platform mAb production process Susan A. Casnocha
3:20 PM	221	Use of mathematical modeling to enable effective implementation of platform aeration strategies in process scale-up and transfer Gregg Nyberg, Franqui Jimenez, Frank Olsen, Gustavo Grampp
3:40 PM	222	Robustness screening to enable cell culture process commercialization Andrew Michael Rusiniak, Tongtong Wang, Guillermo Miroquesada
4:00 PM		Intermission
4:20 PM	223	Process improvement through media development Wang Wenge
	224	Paper Withdrawn
5:00 PM	225	Rapid upstream commercial development of an Escherichia coli.-based process for producing therapeutic proteins in inclusion bodies Henry Lin, Irene Liu, Hedieh Barkhordarian, Jonathan Lull, Xiaoming Yang

Previous Session -- Commercialization of Biologics: Characterization and Improvement of Platforms to Aid Commercialization of Biologics